Muscle Mitochondrial Pyruvate Carrier Disruption Alters Amino Acid Metabolism to Maintain Muscle Mass During Recovery from Obesity
肌肉线粒体丙酮酸载体破坏改变氨基酸代谢,以在肥胖恢复过程中维持肌肉质量
基本信息
- 批准号:10314711
- 负责人:
- 金额:$ 3.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-08 至 2024-06-08
- 项目状态:已结题
- 来源:
- 关键词:AcidsAcuteAddressAffectAgeAlanineAmino AcidsAnabolismAspartateBody CompositionBody WeightBody Weight decreasedBranched-Chain Amino AcidsCell Culture TechniquesChronicCitric Acid CycleDataDiabetes MellitusDietDisease OutcomeExcretory functionFatty acid glycerol estersFellowshipGenerationsGeneticGlucoseGlycolysisGoalsHealthHyperglycemiaInsulinInsulin ResistanceInterventionKnock-outKnowledgeLabelLinkLiverMaintenanceMeasurementMetabolicMetabolic DiseasesMetabolismMissionMitochondriaModelingMusMuscleMuscle FibersMuscle MitochondriaMuscle ProteinsMuscular AtrophyNitrogenNon-Insulin-Dependent Diabetes MellitusObesityOrganOutcomePathogenesisPatientsPhysiciansPlant RootsProductionProtein BiosynthesisProteinsPublic HealthPublishingPuromycinPyruvatePyruvate Metabolism PathwayRecoveryResearchRisk FactorsScientistSkeletal MuscleTestingThinnessTissuesTrainingTransfer RNA AminoacylationUnited States National Institutes of HealthWeightWild Type MouseWorkamino acid metabolismbasecareerdiabetes pathogenesisexperimental studyglucose disposalglucose uptakehepatic gluconeogenesisimprovedinsulin sensitivitymuscle formnitrogen balancenovelobesity treatmentoxidationpolypeptidepreservationpreventpyruvate carriersarcopeniaskeletal muscle metabolismskeletal muscle wastingstable isotopeuptake
项目摘要
Project Summary/Abstract
Type 2 diabetes (T2D) is a widespread metabolic disorder that is characterized by insulin resistance
and hyperglycemia. Obesity, the excess accumulation of fat mass, is a major T2D risk factor and is strongly
associated with insulin resistance in skeletal muscle and liver, resulting in less glucose uptake by both organs.
Reduced muscle glucose uptake contributes to chronic hyperglycemia and is further exacerbated by excessive
hepatic gluconeogenesis. Because skeletal muscle is the largest tissue depot available for glucose disposal,
sarcopenia, the loss of skeletal muscle mass, also contributes to hyperglycemia. Though obesity and
sarcopenia are key factors that contribute to the pathogenesis of T2D, current therapies address insulin
availability or sensitivity without addressing the underlying imbalance between fat and muscle mass.
Disruption of the skeletal muscle mitochondrial pyruvate carrier (MPC) increases insulin sensitivity and
accelerates fat loss with complete muscle mass sparing in mice recovering from obesity. Thus, modulating
skeletal muscle pyruvate metabolism may be useful for treating altered body composition as a T2D root cause.
Our previous work has focused on understanding how muscle-specific MPC disruption increases fat oxidation.
However, how skeletal muscle MPC disruption maintains lean mass during fat mass loss is still not understood.
Therefore, the overall goal of this proposal is to understand how disrupting skeletal muscle mitochondrial
pyruvate uptake spares muscle mass during recovery from obesity. Based on our preliminary data, the central
hypothesis of this proposal is that muscle MPC disruption leads to muscle mass sparing during recovery from
obesity through: 1) a whole-body mechanism of altered substrate exchange between muscle and liver that
spares nitrogen for muscle mass; and 2) a unique, MPC disruption-dependent, muscle-autonomous
mechanism of nitrogen retention. Experiments for specific aim 1 will test the hypothesis that muscle MPC
disruption increases Cori Cycling, the exchange of lactate and glucose between muscle and liver, which spares
nitrogen for skeletal muscle protein and amino acid synthesis during weight loss and recovery from obesity.
Experiments for specific aim 2 will test the hypothesis that skeletal muscle MPC disruption increases aspartate
and branched-chain amino acid (BCAA) availability that leads to maintenance of myocellular protein content.
This research is significant because completion will provide mechanistic information on a way to alter skeletal
muscle metabolism that may inform treatment of obesity and sarcopenia contributing to T2D. This research is
novel because it addresses new concepts in cellular and systemic nitrogen handling.
项目总结/摘要
2型糖尿病(T2 D)是一种广泛的代谢紊乱,其特征在于胰岛素抵抗
和高血糖症。肥胖,即脂肪量的过度积累,是T2 D的主要风险因素,
与骨骼肌和肝脏中的胰岛素抵抗相关,导致两个器官的葡萄糖摄取减少。
减少的肌肉葡萄糖摄取有助于慢性高血糖症,并且过度的葡萄糖摄取会进一步加剧慢性高血糖症。
肝再生因为骨骼肌是最大的可用于葡萄糖处置的组织库,
肌肉减少症,即骨骼肌质量的损失,也有助于高血糖症。虽然肥胖和
肌肉减少症是导致T2 D发病机制的关键因素,目前的治疗方法针对胰岛素
可用性或敏感性,而不解决脂肪和肌肉质量之间的潜在不平衡。
骨骼肌线粒体丙酮酸载体(MPC)的破坏增加了胰岛素敏感性,
在从肥胖症恢复的小鼠中加速脂肪损失并保留完整的肌肉质量。因此,调制
骨骼肌丙酮酸代谢可用于治疗作为T2 D根本原因的改变的身体组成。
我们以前的工作集中在了解肌肉特异性MPC破坏如何增加脂肪氧化。
然而,骨骼肌MPC破坏如何在脂肪量减少期间维持瘦体重仍然不清楚。
因此,这项建议的总体目标是了解如何破坏骨骼肌线粒体
丙酮酸摄取在从肥胖恢复期间节省肌肉质量。根据我们的初步数据,
该建议的假设是,肌肉MPC中断导致肌肉质量在从
肥胖通过:1)改变肌肉和肝脏之间的底物交换的全身机制,
为肌肉质量提供氮;和2)独特的,MPC破坏依赖的,肌肉自主的
氮素滞留机理具体目标1的实验将检验肌肉MPC
破坏增加了科里循环,肌肉和肝脏之间的乳酸盐和葡萄糖交换,
减肥和肥胖恢复期间骨骼肌蛋白质和氨基酸合成的氮。
具体目标2的实验将检验骨骼肌MPC破坏增加天冬氨酸
和支链氨基酸(BCAA)的可用性,导致维持肌细胞蛋白质含量。
这项研究是重要的,因为完成将提供一种改变骨骼的方式的机械信息,
肌肉代谢,可能为治疗肥胖症和导致T2 D的肌肉减少症提供信息。本研究是
新颖,因为它提出了细胞和系统氮处理的新概念。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jane Buchanan其他文献
Jane Buchanan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jane Buchanan', 18)}}的其他基金
Muscle Mitochondrial Pyruvate Carrier Disruption Alters Amino Acid Metabolism to Maintain Muscle Mass During Recovery from Obesity
肌肉线粒体丙酮酸载体破坏改变氨基酸代谢,以在肥胖恢复过程中维持肌肉质量
- 批准号:
10618365 - 财政年份:2021
- 资助金额:
$ 3.67万 - 项目类别:
Muscle Mitochondrial Pyruvate Carrier Disruption Alters Amino Acid Metabolism to Maintain Muscle Mass During Recovery from Obesity
肌肉线粒体丙酮酸载体破坏改变氨基酸代谢,以在肥胖恢复过程中维持肌肉质量
- 批准号:
10468660 - 财政年份:2021
- 资助金额:
$ 3.67万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 3.67万 - 项目类别:
Standard Grant